TAF9 Recombinant Human, TAF9 Human, 20ug

CAT No.BT-ENZ-065

TAF9 Recombinant Human, TAF9 Human, 20ug

---

Amino acid sequence
MGSSHHHHHH SSGLVPRGSH MLLPNILLTG TPGVGKTTLG KELASKSGLK YINVGDLARE EQLYDGYDEE YDCPILDEDR VVDELDNQMR EGGVIVDYHG CDFFPERWFH IVFVLRTDTN VLYERLETRG YNEKKLTDNI QCEIFQVLYE EATASYKEEI VHQLPSNKPE ELENNVDQIL  KWIEQWIKDH NS

Description
TAF9 produced in E.Coli is a single, non-glycosylated polypeptide chain containing 192 amino acids (1-172.a.a) and having a molecular mass of 22.2kDa.
TAF9 is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Formulation
TAF9 Human solution (0.5mg/1ml) containing 20mM Trsi HCL pH-8, 1mM DTT and 10% glycerol.

Sterile filtered colorless solution.

Purity
Greater than 90% as determined by SDS-PAGE.

Source
Escherichia Coli.

Storage
Store at 4¡ãC if entire vial will be used within 2-4 weeks. Store, frozen at -20¡ãC for longer periods of time.
Please avoid freeze thaw cycles.

Synonyms
TAF9 RNA polymerase II TATA box binding protein (TBP)-associated factor 32kDa, TAFII32, AK6, CINAP, TAFII31, TAF2G, CGI-137, MGC1603, MGC3647, MGC5067, TAFIID32, Coilin-interacting nuclear ATPase protein, Transcription initiation factor TFIID 31/32 kDa subunit, STAF31/32, ATP-AMP transphosphorylase 6, h RNA polymerase II TBP-associated factor subunit G, CINAP, AD-004, CIP, adenylate kinase isoenzyme 6, adrenal gland protein AD-004, coilin interacting protein, MGC:1603, MGC:3647, MGC:5067, EC 2.7.4.3.

Usage
TSZGENE's products are furnished for?LABORATORY RESEARCH?USE?ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.